New search Hide text from Guidelines
B BLOOD AND BLOOD FORMING ORGANSB02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
| The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.). |
B02BX Other systemic hemostatics
This group comprises systemic hemostatics, which cannot be classified elsewhere.
| The DDD for avatrombopag is based on the starting dose in the treatment of chronic immune thrombocytopenia. |
| ATC code | Name | DDD | U | Adm.R | Note |
| B02BX01 | etamsylate | ||||
| B02BX02 | carbazochrome | ||||
| B02BX03 | batroxobin | ||||
| B02BX04 | romiplostim | 30 | mcg | P | |
| B02BX05 | eltrombopag | 50 | mg | O | |
| B02BX06 | emicizumab | 15 | mg | P | |
| B02BX07 | lusutrombopag | ||||
| B02BX08 | avatrombopag | 20 | mg | O | |
| B02BX09 | fostamatinib | 0.2 | g | O | |
| B02BX10 | concizumab | ||||
| B02BX11 | marstacimab |
Last updated: 2024-12-27